unanswered questions in psma-targeted radionuclide therapy
Published 3 years ago • 165 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
1:51
dr. tagawa on remaining questions with psma-targeted radionuclide therapy in mcrpc
-
3:42
unanswered questions for the use of psma pet in the staging of prostate cancer
-
1:36
advances in psma-targeted therapy for prostate cancer
-
2:45
arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
-
1:26
remaining questions on psma pet imaging in prostate cancer
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy
-
1:51
psma-targeted therapy in prostate cancer
-
4:42
psma-targeted imaging with 18f-dcfpyl-pet/ct in patients with prostate cancer
-
4:48
vision: lu-177-psma-617 in mcrpc
-
10:09
psma targeted therapies and the role of the urologist
-
6:45
177lu-psma-617 for prostate cancer: therap, vision, upfrontpsma and lutectomy
-
3:56
vision: 177lu-psma-617 in psma-positive mcrpc
-
5:47
phase i/ii dose-escalation study of 225ac-j591 in progressive mcrpc
-
0:53
psma-targeted therapy: a new hope for prostate cancer
-
2:02
osprey: psma-targeted pet-ct imaging in prostate cancer
-
35:05
psma and beyond psma for prostate cancer
-
15:37
psma pet imaging modalities a 'game changer' in prostate cancer
-
1:45
psma-targeted therapies in clinical development show promise for prostate cancer
-
7:15
michael morris, md discusses the future of psma-targeted therapies in apc - part 1